Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 Inventory

Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's inventory stands at $17M as of June 2026. That compares with $12M in the prior-year period — up 46.4% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 reported $17M in inventory versus $12M a year earlier — a 46.4% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $12M in the prior-year period — up 46.4% year over year. Sustained growth in inventory can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's inventory evolved across reporting periods, while the comparison chart places HROWM next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, inventory is commonly used to spot outliers. Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's reading of $17M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.